AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Reach your audience today.

Corporate Spotlight
Announcements
Filter Results
| PIO | Presentation 121 Conference Hong Kong | 23/04/18 | ||
| PIO | Drilling Confirms Continuity of High Grade Caesium | PRICE SENSITIVE | 19/04/18 | |
| PIO | Appendix 3B | 06/04/18 | ||
| PIO | Assays Confirm Wide Lithium Spodumene Pegmatite Intersects | PRICE SENSITIVE | 06/04/18 | |
| PIO | Change of Director's Interest Notice - D Crook | 26/03/18 | ||
| PIO | Appendix 3B - performance rights | 21/03/18 | ||
| PIO | Brisbane Energy Conference Presentation | 13/03/18 | ||
| PIO | December 2017 Half Yearly Report and Accounts | 02/03/18 | ||
| PIO | Presentation RIU Explorers Conference | 22/02/18 | ||
| PIO | Sinclair Zone Project update | PRICE SENSITIVE | 17/01/18 | |
| PIO Presentation 121 Conference Hong Kong | |||
| 23/04/18 | |||
| PIO Drilling Confirms Continuity of High Grade Caesium | |||
| 19/04/18 | PRICE SENSITIVE | ||
| PIO Appendix 3B | |||
| 06/04/18 | |||
| PIO Assays Confirm Wide Lithium Spodumene Pegmatite Intersects | |||
| 06/04/18 | PRICE SENSITIVE | ||
| PIO Change of Director's Interest Notice - D Crook | |||
| 26/03/18 | |||
| PIO Appendix 3B - performance rights | |||
| 21/03/18 | |||
| PIO Brisbane Energy Conference Presentation | |||
| 13/03/18 | |||
| PIO December 2017 Half Yearly Report and Accounts | |||
| 02/03/18 | |||
| PIO Presentation RIU Explorers Conference | |||
| 22/02/18 | |||
| PIO Sinclair Zone Project update | |||
| 17/01/18 | PRICE SENSITIVE | ||
